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IS THERE A RELATIONSHIP BETWEEN CEREBRAL 
ATHEROSCLEROSIS AND ALZHEIMER'S DISEASE? 
Vicki Whitcomb, Department of Psychology, IWU, John Lee*, Department of 
Neuropathology, Loyola University, and Wayne Dornan* Department of 
Psychology, IWU 
Alzheimer's Disease (AD) is a progressive degenerative disorder of the brain 
clinically manifested by cognitive deterioration. It usually begins in later life 
(> 65 years old),  and results in death in about 3 to 10 years. Although 
originally thought to be a rare disease, AD has now reached startling 
proportions. Indeed, AD is the fourth leading cause of death in adults, after 
heart disease, cancer and stroke, and is the most common form of dementia. 
Currently, 4 million Americans have AD, 19 million Americans say they have 
a family member with AD, and 37 million know someone with AD. Although 
significant progress has been made toward understanding the etiology of AD, 
presently there is no known cause or treatment. One neuropathological 
hallmark of Alzheimer's Disease (AD) is the extracellular deposition in the 
cerebral cortex, hippocampus, and basal forebrain of insoluble aggregates of 
a 40-42 amino acid long peptide called B-amyloid peptide (BAPl-42). This 
BAP is derived from a larger transmembrane precursor protein by an 
unknown proteolytic mechanism . .  Since the molecular events that are 
triggered during an ischemic stroke are similar to those that have been 
proposed for AD, we investigated whether age of onset of AD and the extent 
of amyloid deposition is different in neuropathologically conformed cases of 
AD in people with atherosclerosis compared to AD patients without 
cerebrovascular disease. The results of this analysis will be presented at the 
conference. 
